ProDGNE-Novel therapeutic approaches to target GNE myopathy

Videira, P. A. (Chair)

DCV - Departamento de Ciências da Vida

Activity: Other › Types of Award - Other distinction

Description

ProDGNE-Novel therapeutic approaches to target GNE myopathy (Refª FCT: EJPRD/0001/2020) 2021, Total Funding: 1056131€ Unit Funding: 250000 € start 2021-04-01, end date:2024-04-01

Period	1 Apr 2021 → 1 Apr 2024
Degree of Recognition	International

ProDGNE-Novel therapeutic approaches to target GNE myopathy

Description

Related content

Projects

Novas estratégias terapêuticas para miopatia GNE